Rank | Gene Set | Z-score |
---|---|---|
1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.36618179 |
2 | epoxygenase P450 pathway (GO:0019373) | 8.31057952 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58625542 |
4 | L-phenylalanine catabolic process (GO:0006559) | 7.58625542 |
5 | L-phenylalanine metabolic process (GO:0006558) | 7.25378821 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25378821 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 6.91395373 |
8 | indole-containing compound catabolic process (GO:0042436) | 6.33788121 |
9 | indolalkylamine catabolic process (GO:0046218) | 6.33788121 |
10 | tryptophan catabolic process (GO:0006569) | 6.33788121 |
11 | kynurenine metabolic process (GO:0070189) | 6.14354478 |
12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.02242813 |
13 | drug metabolic process (GO:0017144) | 6.01565921 |
14 | bile acid biosynthetic process (GO:0006699) | 5.98240019 |
15 | tryptophan metabolic process (GO:0006568) | 5.95732456 |
16 | glyoxylate metabolic process (GO:0046487) | 5.95087499 |
17 | oxidative demethylation (GO:0070989) | 5.89621652 |
18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56223398 |
19 | cysteine metabolic process (GO:0006534) | 5.54277567 |
20 | urea cycle (GO:0000050) | 5.53393480 |
21 | urea metabolic process (GO:0019627) | 5.53393480 |
22 | ethanol metabolic process (GO:0006067) | 5.35639642 |
23 | sulfur amino acid catabolic process (GO:0000098) | 5.33671743 |
24 | negative regulation of fibrinolysis (GO:0051918) | 5.31186754 |
25 | complement activation, alternative pathway (GO:0006957) | 5.24962365 |
26 | high-density lipoprotein particle remodeling (GO:0034375) | 5.22050019 |
27 | serine family amino acid catabolic process (GO:0009071) | 5.21239325 |
28 | protein carboxylation (GO:0018214) | 5.20246696 |
29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.20246696 |
30 | regulation of protein activation cascade (GO:2000257) | 5.18437616 |
31 | regulation of fibrinolysis (GO:0051917) | 5.14051939 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.09818239 |
33 | bile acid metabolic process (GO:0008206) | 5.08750017 |
34 | regulation of plasminogen activation (GO:0010755) | 5.08504488 |
35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04144973 |
36 | aromatic amino acid family metabolic process (GO:0009072) | 5.02005043 |
37 | lysine metabolic process (GO:0006553) | 4.99811204 |
38 | lysine catabolic process (GO:0006554) | 4.99811204 |
39 | homocysteine metabolic process (GO:0050667) | 4.91695816 |
40 | phenylpropanoid metabolic process (GO:0009698) | 4.88177278 |
41 | regulation of complement activation (GO:0030449) | 4.86531259 |
42 | tyrosine metabolic process (GO:0006570) | 4.73087499 |
43 | negative regulation of blood coagulation (GO:0030195) | 4.72667535 |
44 | negative regulation of hemostasis (GO:1900047) | 4.72667535 |
45 | alpha-amino acid catabolic process (GO:1901606) | 4.72413178 |
46 | amino-acid betaine metabolic process (GO:0006577) | 4.70283458 |
47 | S-adenosylmethionine metabolic process (GO:0046500) | 4.69764116 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 4.61559018 |
49 | reverse cholesterol transport (GO:0043691) | 4.55374003 |
50 | cellular ketone body metabolic process (GO:0046950) | 4.54748675 |
51 | regulation of cholesterol esterification (GO:0010872) | 4.53662636 |
52 | indolalkylamine metabolic process (GO:0006586) | 4.48560171 |
53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.48510743 |
54 | protein-lipid complex remodeling (GO:0034368) | 4.48510743 |
55 | macromolecular complex remodeling (GO:0034367) | 4.48510743 |
56 | triglyceride homeostasis (GO:0070328) | 4.47657267 |
57 | acylglycerol homeostasis (GO:0055090) | 4.47657267 |
58 | negative regulation of cholesterol transport (GO:0032375) | 4.45882443 |
59 | negative regulation of sterol transport (GO:0032372) | 4.45882443 |
60 | coenzyme catabolic process (GO:0009109) | 4.44488528 |
61 | glycine metabolic process (GO:0006544) | 4.42205393 |
62 | cellular glucuronidation (GO:0052695) | 4.39479044 |
63 | amine catabolic process (GO:0009310) | 4.39254979 |
64 | cellular biogenic amine catabolic process (GO:0042402) | 4.39254979 |
65 | cellular amino acid catabolic process (GO:0009063) | 4.36776392 |
66 | acute-phase response (GO:0006953) | 4.36065748 |
67 | bile acid and bile salt transport (GO:0015721) | 4.35484023 |
68 | glutamate metabolic process (GO:0006536) | 4.35325133 |
69 | serine family amino acid metabolic process (GO:0009069) | 4.31191728 |
70 | negative regulation of coagulation (GO:0050819) | 4.29857586 |
71 | imidazole-containing compound metabolic process (GO:0052803) | 4.28889111 |
72 | phospholipid efflux (GO:0033700) | 4.27193038 |
73 | ethanol oxidation (GO:0006069) | 4.24390569 |
74 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.23737967 |
75 | regulation of humoral immune response (GO:0002920) | 4.21657137 |
76 | negative regulation of protein activation cascade (GO:2000258) | 4.20265350 |
77 | cellular modified amino acid catabolic process (GO:0042219) | 4.19625363 |
78 | negative regulation of wound healing (GO:0061045) | 4.19561790 |
79 | benzene-containing compound metabolic process (GO:0042537) | 4.19216258 |
80 | drug catabolic process (GO:0042737) | 4.15426058 |
81 | plasma lipoprotein particle clearance (GO:0034381) | 4.15341606 |
82 | alkaloid metabolic process (GO:0009820) | 4.12868552 |
83 | response to mercury ion (GO:0046689) | 4.11025497 |
84 | serine family amino acid biosynthetic process (GO:0009070) | 4.08060356 |
85 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05545531 |
86 | positive regulation of blood coagulation (GO:0030194) | 4.01427691 |
87 | positive regulation of hemostasis (GO:1900048) | 4.01427691 |
88 | aldehyde catabolic process (GO:0046185) | 3.99679642 |
89 | intestinal cholesterol absorption (GO:0030299) | 3.97585595 |
90 | cholesterol efflux (GO:0033344) | 3.96897833 |
91 | glucuronate metabolic process (GO:0019585) | 3.93736925 |
92 | uronic acid metabolic process (GO:0006063) | 3.93736925 |
93 | ketone body metabolic process (GO:1902224) | 3.93596349 |
94 | arginine metabolic process (GO:0006525) | 3.92896507 |
95 | opsonization (GO:0008228) | 3.92628070 |
96 | short-chain fatty acid metabolic process (GO:0046459) | 3.92019409 |
97 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.89430480 |
98 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.89430480 |
99 | acetyl-CoA metabolic process (GO:0006084) | 3.88364678 |
100 | urate metabolic process (GO:0046415) | 3.84285399 |
101 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83773867 |
102 | regulation of bile acid biosynthetic process (GO:0070857) | 3.83171896 |
103 | carboxylic acid catabolic process (GO:0046395) | 3.82945075 |
104 | organic acid catabolic process (GO:0016054) | 3.82945075 |
105 | fibrinolysis (GO:0042730) | 3.82760999 |
106 | drug transmembrane transport (GO:0006855) | 3.81276715 |
107 | plasma lipoprotein particle assembly (GO:0034377) | 3.75804753 |
108 | flavonoid metabolic process (GO:0009812) | 3.75172883 |
109 | negative regulation of lipase activity (GO:0060192) | 3.74171379 |
110 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.74152992 |
111 | regulation of cholesterol homeostasis (GO:2000188) | 3.73516149 |
112 | cofactor catabolic process (GO:0051187) | 3.73021229 |
113 | hormone catabolic process (GO:0042447) | 3.71508948 |
114 | positive regulation of coagulation (GO:0050820) | 3.71335588 |
115 | complement activation, classical pathway (GO:0006958) | 3.67989809 |
116 | polyketide metabolic process (GO:0030638) | 3.67447161 |
117 | doxorubicin metabolic process (GO:0044598) | 3.67447161 |
118 | daunorubicin metabolic process (GO:0044597) | 3.67447161 |
119 | aspartate family amino acid catabolic process (GO:0009068) | 3.66987449 |
120 | phospholipid homeostasis (GO:0055091) | 3.66881186 |
121 | exogenous drug catabolic process (GO:0042738) | 3.66742246 |
122 | cytolysis (GO:0019835) | 3.65464369 |
123 | cholesterol homeostasis (GO:0042632) | 3.65046245 |
124 | complement activation (GO:0006956) | 3.64316339 |
125 | blood coagulation, intrinsic pathway (GO:0007597) | 3.63287926 |
126 | positive regulation of lipid catabolic process (GO:0050996) | 3.60976817 |
127 | sterol homeostasis (GO:0055092) | 3.60020991 |
128 | 2-oxoglutarate metabolic process (GO:0006103) | 3.58781450 |
129 | protein activation cascade (GO:0072376) | 3.58631408 |
130 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58330650 |
131 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58330650 |
132 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58213875 |
133 | heme transport (GO:0015886) | 3.55050596 |
134 | primary alcohol catabolic process (GO:0034310) | 3.53561806 |
135 | xenobiotic metabolic process (GO:0006805) | 3.48731024 |
136 | sodium-independent organic anion transport (GO:0043252) | 3.46306068 |
137 | negative regulation of complement activation (GO:0045916) | 3.39636891 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34610592 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14562030 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92925396 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46301434 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23229717 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.91323096 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.91220312 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03504841 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.90448026 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08409418 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06070918 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01144867 |
13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8137172 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62374443 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58018523 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52349822 |
17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42400288 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36453315 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22209521 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21389140 |
21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17701365 |
22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15380993 |
23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09380093 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05634014 |
25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04962784 |
26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04697859 |
27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04695421 |
28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96213673 |
29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95247795 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94084944 |
31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90418791 |
32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.89820115 |
33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89249052 |
34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88173663 |
35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86676786 |
36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84727971 |
37 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83815933 |
38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81862204 |
39 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.80685654 |
40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79861442 |
41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78405774 |
42 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.78261349 |
43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78135688 |
44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74985547 |
45 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74541815 |
46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73767839 |
47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73096449 |
48 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.73092012 |
49 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71741318 |
50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71739241 |
51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71302474 |
52 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70976249 |
53 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.70677547 |
54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70354248 |
55 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68804926 |
56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68599849 |
57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68473273 |
58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68473273 |
59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66195323 |
60 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.65038159 |
61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64407441 |
62 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64084234 |
63 | NFYA_21822215_ChIP-Seq_K562_Human | 0.63864403 |
64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63583153 |
65 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.63408748 |
66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63262804 |
67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.62072637 |
68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61951685 |
69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.61354230 |
70 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61204522 |
71 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60674148 |
72 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.60633871 |
73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.59430379 |
74 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58683241 |
75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.58573602 |
76 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.58078972 |
77 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.58053712 |
78 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.57855389 |
79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.57540080 |
80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56939607 |
81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.56842532 |
82 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56079008 |
83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55339315 |
84 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54528666 |
85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53939187 |
86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53546698 |
87 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53533669 |
88 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53404497 |
89 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53321705 |
90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.53087093 |
91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53082477 |
92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.52889516 |
93 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.52821956 |
94 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52681110 |
95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52530295 |
96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.52037898 |
97 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51595920 |
98 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51438749 |
99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.51211430 |
100 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50932883 |
101 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.50713578 |
102 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50671546 |
103 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.49895516 |
104 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48976192 |
105 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.48082104 |
106 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47461199 |
107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.47404801 |
108 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.46836672 |
109 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.46390156 |
110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45010899 |
111 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.44360317 |
112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43378151 |
113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43332579 |
114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43147847 |
115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43126200 |
116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42961337 |
117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42937784 |
118 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42311173 |
119 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.42000709 |
120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41823638 |
121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41686484 |
122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40883348 |
123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40725983 |
124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40517671 |
125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40190838 |
126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38783166 |
127 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.38687369 |
128 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38268733 |
129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36981136 |
130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36497610 |
131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36263054 |
132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.36235972 |
133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35594242 |
134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34999992 |
135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34782280 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.31137312 |
2 | MP0005360_urolithiasis | 7.77455506 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.36552934 |
4 | MP0005365_abnormal_bile_salt | 6.06152305 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14006760 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.20456541 |
7 | MP0003252_abnormal_bile_duct | 3.94316596 |
8 | MP0010329_abnormal_lipoprotein_level | 3.48897245 |
9 | MP0009840_abnormal_foam_cell | 3.07599080 |
10 | MP0003195_calcinosis | 2.98564164 |
11 | MP0005083_abnormal_biliary_tract | 2.98419409 |
12 | MP0005332_abnormal_amino_acid | 2.94630133 |
13 | MP0001666_abnormal_nutrient_absorption | 2.55903604 |
14 | MP0004019_abnormal_vitamin_homeostasis | 2.34800060 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.17563283 |
16 | MP0000609_abnormal_liver_physiology | 2.11507538 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.08431089 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.06397144 |
19 | MP0005319_abnormal_enzyme/_coenzyme | 1.84995664 |
20 | MP0003868_abnormal_feces_composition | 1.83254120 |
21 | MP0001764_abnormal_homeostasis | 1.66034213 |
22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60223424 |
23 | MP0009697_abnormal_copulation | 1.49096040 |
24 | MP0005451_abnormal_body_composition | 1.42247022 |
25 | MP0009643_abnormal_urine_homeostasis | 1.40662063 |
26 | MP0003186_abnormal_redox_activity | 1.31905858 |
27 | MP0003011_delayed_dark_adaptation | 1.24289330 |
28 | MP0000598_abnormal_liver_morphology | 1.14958261 |
29 | MP0003656_abnormal_erythrocyte_physiolo | 1.14069558 |
30 | MP0005647_abnormal_sex_gland | 1.13774972 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.09029945 |
32 | MP0002132_abnormal_respiratory_system | 1.06436514 |
33 | MP0009764_decreased_sensitivity_to | 1.05778833 |
34 | MP0005636_abnormal_mineral_homeostasis | 1.04829726 |
35 | MP0000604_amyloidosis | 1.01251844 |
36 | MP0002254_reproductive_system_inflammat | 0.99218787 |
37 | MP0009763_increased_sensitivity_to | 0.97505070 |
38 | MP0010368_abnormal_lymphatic_system | 0.88361441 |
39 | MP0006036_abnormal_mitochondrial_physio | 0.88356095 |
40 | MP0008469_abnormal_protein_level | 0.87260704 |
41 | MP0005670_abnormal_white_adipose | 0.87169684 |
42 | MP0009642_abnormal_blood_homeostasis | 0.87125500 |
43 | MP0003879_abnormal_hair_cell | 0.86902181 |
44 | MP0005084_abnormal_gallbladder_morpholo | 0.85266167 |
45 | MP0002876_abnormal_thyroid_physiology | 0.84958430 |
46 | MP0005408_hypopigmentation | 0.82239448 |
47 | MP0002078_abnormal_glucose_homeostasis | 0.78271554 |
48 | MP0005376_homeostasis/metabolism_phenot | 0.77050923 |
49 | MP0009765_abnormal_xenobiotic_induced | 0.75303415 |
50 | MP0002971_abnormal_brown_adipose | 0.74413629 |
51 | MP0001915_intracranial_hemorrhage | 0.74076822 |
52 | MP0005535_abnormal_body_temperature | 0.73561476 |
53 | MP0005220_abnormal_exocrine_pancreas | 0.73502069 |
54 | MP0004130_abnormal_muscle_cell | 0.73395479 |
55 | MP0001756_abnormal_urination | 0.72931809 |
56 | MP0001661_extended_life_span | 0.71981978 |
57 | MP0005334_abnormal_fat_pad | 0.69316001 |
58 | MP0003690_abnormal_glial_cell | 0.67675944 |
59 | MP0003646_muscle_fatigue | 0.65523925 |
60 | MP0005266_abnormal_metabolism | 0.63717043 |
61 | MP0003329_amyloid_beta_deposits | 0.63564903 |
62 | MP0002332_abnormal_exercise_endurance | 0.62354846 |
63 | MP0006035_abnormal_mitochondrial_morpho | 0.59955780 |
64 | MP0002136_abnormal_kidney_physiology | 0.59870853 |
65 | MP0009053_abnormal_anal_canal | 0.58059314 |
66 | MP0005187_abnormal_penis_morphology | 0.57410100 |
67 | MP0005375_adipose_tissue_phenotype | 0.55803789 |
68 | MP0003959_abnormal_lean_body | 0.54375750 |
69 | MP0002928_abnormal_bile_duct | 0.53664587 |
70 | MP0005023_abnormal_wound_healing | 0.53160302 |
71 | MP0005448_abnormal_energy_balance | 0.52888878 |
72 | MP0000639_abnormal_adrenal_gland | 0.52804838 |
73 | MP0009785_altered_susceptibility_to | 0.52563420 |
74 | MP0004043_abnormal_pH_regulation | 0.51501247 |
75 | MP0003638_abnormal_response/metabolism_ | 0.49507215 |
76 | MP0002282_abnormal_trachea_morphology | 0.49456341 |
77 | MP0005395_other_phenotype | 0.48699627 |
78 | MP0005164_abnormal_response_to | 0.47440171 |
79 | MP0002822_catalepsy | 0.46536999 |
80 | MP0002837_dystrophic_cardiac_calcinosis | 0.46230603 |
81 | MP0005666_abnormal_adipose_tissue | 0.45793203 |
82 | MP0008874_decreased_physiological_sensi | 0.45346184 |
83 | MP0002249_abnormal_larynx_morphology | 0.44130945 |
84 | MP0003724_increased_susceptibility_to | 0.43896213 |
85 | MP0005464_abnormal_platelet_physiology | 0.43328250 |
86 | MP0005167_abnormal_blood-brain_barrier | 0.42916514 |
87 | MP0003953_abnormal_hormone_level | 0.42296453 |
88 | MP0004782_abnormal_surfactant_physiolog | 0.42004934 |
89 | MP0003718_maternal_effect | 0.41937735 |
90 | MP0008873_increased_physiological_sensi | 0.40681453 |
91 | MP0003075_altered_response_to | 0.39265406 |
92 | MP0005166_decreased_susceptibility_to | 0.38730161 |
93 | MP0002269_muscular_atrophy | 0.38133265 |
94 | MP0000230_abnormal_systemic_arterial | 0.38109566 |
95 | MP0009672_abnormal_birth_weight | 0.37846947 |
96 | MP0003436_decreased_susceptibility_to | 0.36530854 |
97 | MP0008872_abnormal_physiological_respon | 0.36465972 |
98 | MP0002168_other_aberrant_phenotype | 0.36464699 |
99 | MP0001765_abnormal_ion_homeostasis | 0.35780826 |
100 | MP0005248_abnormal_Harderian_gland | 0.35702572 |
101 | MP0004381_abnormal_hair_follicle | 0.35575566 |
102 | MP0002796_impaired_skin_barrier | 0.35081592 |
103 | MP0009115_abnormal_fat_cell | 0.34397899 |
104 | MP0005330_cardiomyopathy | 0.33961464 |
105 | MP0000579_abnormal_nail_morphology | 0.33404754 |
106 | MP0000749_muscle_degeneration | 0.33380290 |
107 | MP0005058_abnormal_lysosome_morphology | 0.32623647 |
108 | MP0009384_cardiac_valve_regurgitation | 0.32434863 |
109 | MP0006082_CNS_inflammation | 0.30754827 |
110 | MP0004036_abnormal_muscle_relaxation | 0.30592298 |
111 | MP0002970_abnormal_white_adipose | 0.30464811 |
112 | MP0000249_abnormal_blood_vessel | 0.28305675 |
113 | MP0001853_heart_inflammation | 0.28123970 |
114 | MP0000751_myopathy | 0.26491491 |
115 | MP0006138_congestive_heart_failure | 0.26229140 |
116 | MP0001845_abnormal_inflammatory_respons | 0.26141570 |
117 | MP0004087_abnormal_muscle_fiber | 0.25939856 |
118 | MP0001881_abnormal_mammary_gland | 0.25921779 |
119 | MP0002135_abnormal_kidney_morphology | 0.25588256 |
120 | MP0001243_abnormal_dermal_layer | 0.25358537 |
121 | MP0003633_abnormal_nervous_system | 0.24639007 |
122 | MP0000920_abnormal_myelination | 0.24532375 |
123 | MP0001851_eye_inflammation | 0.23083785 |
124 | MP0004883_abnormal_blood_vessel | 0.22903602 |
125 | MP0002128_abnormal_blood_circulation | 0.22867461 |
126 | MP0000747_muscle_weakness | 0.22500454 |
127 | MP0005397_hematopoietic_system_phenotyp | 0.21967911 |
128 | MP0001545_abnormal_hematopoietic_system | 0.21967911 |
129 | MP0005452_abnormal_adipose_tissue | 0.21358403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.28609606 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.22232662 |
3 | Deep venous thrombosis (HP:0002625) | 7.10183409 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.46714879 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.27142956 |
6 | Xanthomatosis (HP:0000991) | 6.14504099 |
7 | Hypobetalipoproteinemia (HP:0003563) | 6.11155749 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.32197360 |
9 | Complement deficiency (HP:0004431) | 5.28353263 |
10 | Hyperammonemia (HP:0001987) | 4.65120023 |
11 | Hyperglycinemia (HP:0002154) | 4.61032156 |
12 | Joint hemorrhage (HP:0005261) | 4.60752029 |
13 | Hypolipoproteinemia (HP:0010981) | 4.55150272 |
14 | Ketosis (HP:0001946) | 4.42134992 |
15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.41702873 |
16 | Epidermoid cyst (HP:0200040) | 4.40365153 |
17 | Hyperglycinuria (HP:0003108) | 4.30381880 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24352991 |
19 | Abnormality of glycine metabolism (HP:0010895) | 4.21878514 |
20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.21878514 |
21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.20214041 |
22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.17887877 |
23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16586050 |
24 | Fat malabsorption (HP:0002630) | 4.08749882 |
25 | Abnormality of methionine metabolism (HP:0010901) | 4.08457051 |
26 | Hypoalphalipoproteinemia (HP:0003233) | 3.96465668 |
27 | Nephritis (HP:0000123) | 3.88790147 |
28 | Hypoglycemic coma (HP:0001325) | 3.83227067 |
29 | Abnormality of complement system (HP:0005339) | 3.82786058 |
30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72896053 |
31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.72412070 |
32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.58843482 |
33 | Hypercholesterolemia (HP:0003124) | 3.50665324 |
34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.49203468 |
35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35110218 |
36 | Delayed CNS myelination (HP:0002188) | 3.30187784 |
37 | Ketoacidosis (HP:0001993) | 3.28995592 |
38 | Hyperbilirubinemia (HP:0002904) | 3.28551991 |
39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.22662525 |
40 | Abnormality of serum amino acid levels (HP:0003112) | 3.14613912 |
41 | Steatorrhea (HP:0002570) | 3.08346137 |
42 | Abnormality of purine metabolism (HP:0004352) | 2.97787752 |
43 | Hepatocellular carcinoma (HP:0001402) | 2.95097275 |
44 | Gout (HP:0001997) | 2.94179421 |
45 | Myocardial infarction (HP:0001658) | 2.91342621 |
46 | Metabolic acidosis (HP:0001942) | 2.86442813 |
47 | Hypochromic microcytic anemia (HP:0004840) | 2.78860253 |
48 | Spontaneous abortion (HP:0005268) | 2.76731646 |
49 | Vascular calcification (HP:0004934) | 2.76066308 |
50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72577432 |
51 | Dicarboxylic aciduria (HP:0003215) | 2.72577432 |
52 | Skin nodule (HP:0200036) | 2.72244860 |
53 | Systemic lupus erythematosus (HP:0002725) | 2.70715210 |
54 | Lethargy (HP:0001254) | 2.69237914 |
55 | Purpura (HP:0000979) | 2.50419791 |
56 | Spastic diplegia (HP:0001264) | 2.48097438 |
57 | Osteomalacia (HP:0002749) | 2.47530157 |
58 | Cardiovascular calcification (HP:0011915) | 2.44819083 |
59 | Cerebral edema (HP:0002181) | 2.44769737 |
60 | Hypoglycemic seizures (HP:0002173) | 2.41717477 |
61 | Neonatal onset (HP:0003623) | 2.41290569 |
62 | Mitral stenosis (HP:0001718) | 2.41125226 |
63 | Irritability (HP:0000737) | 2.40465420 |
64 | Acanthocytosis (HP:0001927) | 2.39602324 |
65 | Abnormal gallbladder morphology (HP:0012437) | 2.38276721 |
66 | Malnutrition (HP:0004395) | 2.37411219 |
67 | Generalized aminoaciduria (HP:0002909) | 2.33538396 |
68 | Neonatal hypoglycemia (HP:0001998) | 2.33453585 |
69 | Reduced antithrombin III activity (HP:0001976) | 2.33351524 |
70 | Cholelithiasis (HP:0001081) | 2.32416298 |
71 | Glomerulonephritis (HP:0000099) | 2.32005239 |
72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29983273 |
73 | Fair hair (HP:0002286) | 2.29390041 |
74 | Pulmonary embolism (HP:0002204) | 2.27379632 |
75 | Abnormal gallbladder physiology (HP:0012438) | 2.22447783 |
76 | Cholecystitis (HP:0001082) | 2.22447783 |
77 | Sensorimotor neuropathy (HP:0007141) | 2.22217503 |
78 | Enlarged kidneys (HP:0000105) | 2.20263099 |
79 | Late onset (HP:0003584) | 2.19553022 |
80 | Vomiting (HP:0002013) | 2.19167611 |
81 | Pancreatitis (HP:0001733) | 2.14927027 |
82 | Alkalosis (HP:0001948) | 2.13852081 |
83 | Esophageal varix (HP:0002040) | 2.13461950 |
84 | Rickets (HP:0002748) | 2.10404051 |
85 | Abnormality of vitamin metabolism (HP:0100508) | 2.10363192 |
86 | Hydroxyprolinuria (HP:0003080) | 2.10264804 |
87 | Abnormality of proline metabolism (HP:0010907) | 2.10264804 |
88 | Proximal tubulopathy (HP:0000114) | 2.09634320 |
89 | Brushfield spots (HP:0001088) | 2.09169144 |
90 | Amyloidosis (HP:0011034) | 2.06525514 |
91 | Opisthotonus (HP:0002179) | 2.03505942 |
92 | Menorrhagia (HP:0000132) | 2.03488142 |
93 | Increased purine levels (HP:0004368) | 2.02237634 |
94 | Hyperuricemia (HP:0002149) | 2.02237634 |
95 | Hyperphosphaturia (HP:0003109) | 2.01501882 |
96 | Gingival bleeding (HP:0000225) | 1.99065286 |
97 | Hemorrhage of the eye (HP:0011885) | 1.98097446 |
98 | Thrombophlebitis (HP:0004418) | 1.98032622 |
99 | Abnormality of the gallbladder (HP:0005264) | 1.96600528 |
100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96142102 |
101 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95202328 |
102 | Hypophosphatemic rickets (HP:0004912) | 1.94461613 |
103 | Abnormality of urine glucose concentration (HP:0011016) | 1.89752368 |
104 | Glycosuria (HP:0003076) | 1.89752368 |
105 | Abnormal cartilage morphology (HP:0002763) | 1.88595046 |
106 | Increased mean platelet volume (HP:0011877) | 1.86932845 |
107 | Poikilocytosis (HP:0004447) | 1.86755088 |
108 | Renal cortical cysts (HP:0000803) | 1.86574310 |
109 | Bifid scrotum (HP:0000048) | 1.84485683 |
110 | Abnormality of the Achilles tendon (HP:0005109) | 1.83344313 |
111 | Joint swelling (HP:0001386) | 1.82313030 |
112 | Status epilepticus (HP:0002133) | 1.81995916 |
113 | Arthropathy (HP:0003040) | 1.81148815 |
114 | Elevated hepatic transaminases (HP:0002910) | 1.80092418 |
115 | Atrioventricular block (HP:0001678) | 1.75964164 |
116 | Elevated alkaline phosphatase (HP:0003155) | 1.74641308 |
117 | Increased serum ferritin (HP:0003281) | 1.73526485 |
118 | Abnormality of iron homeostasis (HP:0011031) | 1.70961952 |
119 | Cerebral palsy (HP:0100021) | 1.70400882 |
120 | Abnormal platelet volume (HP:0011876) | 1.67484434 |
121 | Abnormal platelet function (HP:0011869) | 1.65168367 |
122 | Impaired platelet aggregation (HP:0003540) | 1.65168367 |
123 | Hypertriglyceridemia (HP:0002155) | 1.64215611 |
124 | Epistaxis (HP:0000421) | 1.62943785 |
125 | Back pain (HP:0003418) | 1.61607469 |
126 | Gangrene (HP:0100758) | 1.60799274 |
127 | Abnormal urine phosphate concentration (HP:0012599) | 1.59093443 |
128 | Retinal atrophy (HP:0001105) | 1.56781921 |
129 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.55227630 |
130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.55210880 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.24146036 |
2 | SIK1 | 4.56372628 |
3 | FGFR4 | 4.53570957 |
4 | ERN1 | 4.14177199 |
5 | OBSCN | 3.22847338 |
6 | INSRR | 3.01798807 |
7 | TAOK3 | 2.97588758 |
8 | ERBB4 | 2.88437242 |
9 | MAP2K4 | 2.25603226 |
10 | MST1R | 2.20616394 |
11 | PKN2 | 2.06029070 |
12 | PIK3CA | 1.88254832 |
13 | MAPK11 | 1.87386912 |
14 | FLT3 | 1.74601317 |
15 | TRIB3 | 1.73712837 |
16 | PIK3CG | 1.72045191 |
17 | PRPF4B | 1.61039517 |
18 | LATS1 | 1.59870252 |
19 | TYK2 | 1.58573497 |
20 | ABL2 | 1.46411661 |
21 | NTRK3 | 1.46139968 |
22 | PTK6 | 1.44048886 |
23 | DAPK2 | 1.42384013 |
24 | MYLK | 1.39393442 |
25 | PHKG2 | 1.37397654 |
26 | PHKG1 | 1.37397654 |
27 | FGFR2 | 1.36210027 |
28 | FRK | 1.35247458 |
29 | NEK9 | 1.34062735 |
30 | MAP3K7 | 1.31318890 |
31 | PINK1 | 1.25563875 |
32 | KDR | 1.25042559 |
33 | NLK | 1.24099877 |
34 | STK38L | 1.21714813 |
35 | JAK2 | 1.19371859 |
36 | PRKAA2 | 1.19307361 |
37 | PDK2 | 1.18667994 |
38 | MAP3K1 | 1.13968549 |
39 | CAMKK2 | 1.10635299 |
40 | GRK6 | 1.09520123 |
41 | MAP3K14 | 1.05324416 |
42 | PRKG1 | 1.01632589 |
43 | MAP2K3 | 1.01016003 |
44 | JAK1 | 0.98485177 |
45 | ERBB2 | 0.97413551 |
46 | TNK2 | 0.96310614 |
47 | TBK1 | 0.95133106 |
48 | MAPK4 | 0.94063989 |
49 | PRKCZ | 0.93826769 |
50 | MAPKAPK3 | 0.92180170 |
51 | MAP3K10 | 0.89897214 |
52 | TIE1 | 0.87555891 |
53 | WNK3 | 0.87267150 |
54 | MOS | 0.86805782 |
55 | MAPK15 | 0.85447159 |
56 | EPHB1 | 0.84257273 |
57 | MET | 0.83112171 |
58 | MAP3K3 | 0.81156602 |
59 | MAPK12 | 0.80789394 |
60 | SGK3 | 0.77451515 |
61 | CAMK1D | 0.77451467 |
62 | TTN | 0.76394533 |
63 | KSR2 | 0.76100864 |
64 | CDK6 | 0.75607801 |
65 | WNK4 | 0.75532330 |
66 | PRKACG | 0.75302271 |
67 | PRKAA1 | 0.74363433 |
68 | IRAK3 | 0.73814868 |
69 | PRKACA | 0.73565196 |
70 | DYRK1B | 0.73166697 |
71 | GSK3A | 0.72436338 |
72 | ARAF | 0.69422274 |
73 | MAP3K11 | 0.67385387 |
74 | TRPM7 | 0.67331524 |
75 | MAP3K2 | 0.66585310 |
76 | CSK | 0.65925132 |
77 | RIPK1 | 0.65609263 |
78 | CAMK2G | 0.65192927 |
79 | MAP2K6 | 0.64949617 |
80 | FER | 0.64067017 |
81 | PDGFRA | 0.62589739 |
82 | SGK2 | 0.62376086 |
83 | EPHA3 | 0.60923226 |
84 | TGFBR2 | 0.59258166 |
85 | BLK | 0.59140632 |
86 | ZAP70 | 0.58624883 |
87 | PDK4 | 0.58437870 |
88 | PDK3 | 0.58437870 |
89 | EPHA4 | 0.58304621 |
90 | SGK223 | 0.57875623 |
91 | SGK494 | 0.57875623 |
92 | PTK2 | 0.56402222 |
93 | LATS2 | 0.55680139 |
94 | OXSR1 | 0.55132174 |
95 | PDPK1 | 0.54659172 |
96 | FGFR3 | 0.54591027 |
97 | MAPK7 | 0.53347081 |
98 | RPS6KA3 | 0.53270598 |
99 | PRKCQ | 0.50326837 |
100 | SGK1 | 0.48924692 |
101 | MARK3 | 0.48889906 |
102 | PRKACB | 0.48882420 |
103 | CSF1R | 0.47882108 |
104 | DDR2 | 0.47837348 |
105 | MAP3K13 | 0.46443615 |
106 | IKBKE | 0.45865626 |
107 | MUSK | 0.45410385 |
108 | CSNK1G1 | 0.44601599 |
109 | IGF1R | 0.43690725 |
110 | GRK1 | 0.42521657 |
111 | AKT2 | 0.41055549 |
112 | RPS6KB1 | 0.40752302 |
113 | CSNK1D | 0.39860815 |
114 | PKN1 | 0.39020441 |
115 | MAP3K5 | 0.38965314 |
116 | CDC42BPA | 0.38622344 |
117 | TAOK2 | 0.38558220 |
118 | PRKCG | 0.38244704 |
119 | RET | 0.36387061 |
120 | MAP2K1 | 0.36057629 |
121 | CDK4 | 0.35709944 |
122 | CAMK1G | 0.35641476 |
123 | IRAK2 | 0.35561255 |
124 | CAMK4 | 0.33611155 |
125 | PDK1 | 0.33544092 |
126 | MTOR | 0.33093839 |
127 | MAP3K6 | 0.32949234 |
128 | IRAK1 | 0.31745500 |
129 | ICK | 0.30567832 |
130 | EGFR | 0.30201618 |
131 | PAK3 | 0.26977256 |
132 | PRKCA | 0.26964781 |
133 | PBK | 0.26444248 |
134 | CSNK1G2 | 0.22537632 |
135 | STK38 | 0.22158207 |
136 | ABL1 | 0.20831555 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44724855 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48212712 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41927813 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29211170 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97918924 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73112784 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70678692 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66804507 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62250796 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53858207 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52389971 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49036750 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34631677 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.14102996 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11955158 |
16 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.07953356 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05479503 |
18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92880283 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91214220 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89230706 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88986224 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86748836 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84157026 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76194644 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75318940 |
26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71693867 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70450292 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70144366 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69246215 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67366298 |
31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65595374 |
32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62155943 |
33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56561416 |
34 | Bile secretion_Homo sapiens_hsa04976 | 1.53807448 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53538573 |
36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44413997 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41229443 |
38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40355372 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37722139 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31439673 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30189715 |
42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26547237 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19433015 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.19229354 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18973385 |
46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17218244 |
47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16120561 |
48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14517874 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10611863 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09211860 |
51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00256739 |
52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99843081 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98771235 |
54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95494275 |
55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94691389 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91385081 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90929964 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.85969953 |
59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85133678 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73076275 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72964480 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70823171 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69354111 |
64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62041228 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55676538 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53626520 |
67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46372251 |
68 | Pertussis_Homo sapiens_hsa05133 | 0.38338574 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35709723 |
70 | Prion diseases_Homo sapiens_hsa05020 | 0.33744611 |
71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26046955 |
72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24400237 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24321126 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23501001 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22923216 |
76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19248251 |
77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18580099 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13874781 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09632527 |
80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08621345 |
81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02771948 |
82 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2515095 |
83 | Mineral absorption_Homo sapiens_hsa04978 | -0.2331569 |
84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2330136 |
85 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2313246 |
86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2306854 |
87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2284878 |
88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2212692 |
89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2117395 |
90 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1807967 |
91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1789042 |
92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1749121 |
93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1720975 |
94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1638694 |
95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1596304 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1541891 |
97 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1462136 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1418443 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1330449 |
100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1255199 |
101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1075524 |
102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1075417 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1063586 |
104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1055862 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0988530 |
106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0727981 |
107 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0673351 |
108 | Amoebiasis_Homo sapiens_hsa05146 | -0.0465453 |
109 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0267661 |
110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0224145 |